A recombinant influenza virus with a CTLA4‐specific scFv inhibits tumor growth in a mouse model-Reference-Cited by-同舟云学术

A recombinant influenza virus with a CTLA4‐specific scFv inhibits tumor growth in a mouse model

Published:2021-03 Issue: Volume: Page:
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biol Int

Author:

Lei Guang‐Lin¹,Wang Li‐Peng²³,Dong Suo‐Hua¹,Sun Fang¹,Cheng Jin‐Xia¹,Yang Xiao‐Lan⁴,Zhang Shao‐Geng¹,Wang Xi‐Liang⁴,Wang Xin‐Xin³,Yang Peng‐Hui¹^ORCID

Affiliation:

1. Fifth Medical Center of Chinese PLA General Hospital Beijing China

2. 66400 Military Hospital Beijing China

3. First Medical Center of Chinese PLA General Hospital Beijing China

4. State Key Laboratory of Pathogens and Biosecurity Beijing Institute of Microbiology and Epidemiology Beijing China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbin.11559

Reference34 articles.

1. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma;Andtbacka R. H. I.;Journal of Clinical Oncology,2015

2. Unleashing the therapeutic potential of oncolytic viruses;Bommareddy P. K.;Journal of Clinical Investigation,2018

3. Integrating oncolytic viruses in combination cancer immunotherapy;Bommareddy P. K.;Nature Reviews Immunology,2018

4. Antitumor activities of novel glycyrrhetinic acid‐modified curcumin‐loaded cationic liposomes in vitro and in H22 tumor‐bearing mice;Chang M.;Drug Delivery,2018

5. Randomized, open‐label phase II study evaluating the efficacy and safety of talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma;Chesney J.;Journal of Clinical Oncology,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted metabolic role of infections in the tumor microenvironment;Current Opinion in Biotechnology;2024-10

2. Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer;Biomedicine & Pharmacotherapy;2024-10

3. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8 ⁺ T cell function and its impact against pancreatic ductal adenocarcinoma;OncoImmunology;2024-02-27

4. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024

5. Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy;Signal Transduction and Targeted Therapy;2023-11-29